Table 2.
Moderator analysis of cognitively engaging PA and EFs.
| Categorical Variables | Level | No. of Studies |
Cohen’s d | 95%CI | I2% | Heterogeneity between Subgroups | ||
|---|---|---|---|---|---|---|---|---|
| Q | d.f. | p Value | ||||||
| Session length(min) | <35 | 14 | 0.07 | −0.01 to 0.15 | 10.4 | 4.55 | 1 | 0.033 |
| ≥35 | 17 | 0.30 | 0.10 to 0.49 | 71.5 | ||||
| frequency | <3 | 13 | 0.18 | −0.01 to 0.36 | 65.7 | 0.12 | 1 | 0.725 |
| ≥3 | 19 | 0.22 | 0.09 to 0.35 | 62.5 | ||||
| Dose (min)/week |
<100 | 14 | 0.26 | 0.11 to 0.40 | 55.8 | 0.74 | 1 | 0.390 |
| ≥100 | 17 | 0.16 | −0.56 to 0.38 | 63.4 | ||||
| Duration (week) | <10 | 19 | 0.25 | 0.11 to 0.40 | 46.1 | 0.71 | 1 | 0.401 |
| ≥10 | 12 | 0.16 | 0.00 to 0.32 | 71.0 | ||||
| Total dose (min) | <1000 | 18 | 0.23 | 0.08 to 0.37 | 45.7 | 0.08 | 1 | 0.774 |
| ≥1000 | 13 | 0.19 | 0.03 to 0.36 | 76.5 | ||||
| Continuous variables | Level | No. of studies | β | 95%CI | I2% | Adjusted R2% | p value | |
| BMI | 15–25 | 28 | 0.03 | −0.03 to 0.10 | 56.9 | 1.59 | 0.40 | |
| Age | 4–12 | 31 | 0.03 | 0.04 to 0.09 | 63.8 | 5.48 | 0.27 | |